Macrophages and their subpopulations following allogeneic bone marrow transplantation for chronic myeloid leukaemia

被引:14
|
作者
Thiele, J
Kvasnicka, HM
Beelen, DW
Wenzel, P
Koepke, ML
Leder, LD
Schaefer, UW
机构
[1] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany
[2] Univ Essen Gesamthsch, Inst Pathol, Essen, Germany
[3] Univ Essen Gesamthsch, Dept Bone Marrow Transplantat, Essen, Germany
关键词
macrophages; pseudo-Gaucher cells; chronic myeloid leukaemia; bone marrow transplantation; bone marrow biopsies;
D O I
10.1007/s004280000224
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A morphometric and immunohistochemical study was performed on 354 bone marrow trephine biopsies derived from 126 patients with chronic myeloid leukaemia (CML) before and after allogeneic bone marrow transplantation (BMT). The purpose of this investigation was to evaluate the macrophage population, including several subsets and their dynamics in the posttransplant period. In addition to the total CD68(+) resident (mature) macrophages the so-called activated fraction identified by its capacity to express alpha-D-galactosyl residues, the pseudo-Gaucher cells (PGCs) and the iron-laden histiocytic reticular cells were also considered. Following immuno- and lectin-histochemical staining morphometric analysis was carried out on sequential postgraft bone marrow specimens at standardized intervals. Compared to the normal bone marrow and calculated per haematopoiesis (cellularity) an overall decrease of about 40-50% in the quantity of CD68(+) macrophages and the BSA-I+ subpopulation was detectable in the early posttransplant period (9-45 days after BMT). Noteworthy was the temporal recurrence of PGCs in the engrafted bone marrow, which was not associated with a clonally transformed cell population or leukaemic relapse. Reappearance of postgraft PGCs was most prominent in the first 2 months after BMT This conspicuous feature was presumed to be functionally associated with a pronounced degradation of cell debris following pretransplant myelo-ablative therapy (scavenger macrophages). Evidence for an activation of the BSA-I+ macrophage subset was derived from the identical carbohydrate-binding rapacity shown by the PGCs. In the regenerating haematopoiesis shortly after BMT a significant correlation between the number of BSA-I+ macrophages and erythroid precursor cells was determinable. This result implicates a close functional relationship between postgraft reconstitution of erythropoietic islets and centrally localized activated macrophages. In conclusion, findings emerging from this study included the reappearance of PCGs in the engrafted bone marrow independently of a leukaemic relapse and the significant association of the activated BSA-I+ macrophage subset with the recovery of erythropoiesis.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [1] Macrophages and their subpopulations following allogeneic bone marrow transplantation for chronic myeloid leukaemia
    J. Thiele
    H. M. Kvasnicka
    D. W. Beelen
    P. Wenzel
    M. L. Koepke
    L.-D. Leder
    U. W. Schaefer
    [J]. Virchows Archiv, 2000, 437 : 160 - 166
  • [2] Histopathology of bone marrow after allogeneic bone marrow transplantation for chronic myeloid leukaemia
    Rousselet, MC
    Kerjean, A
    Guyetant, S
    Francois, S
    SaintAndre, JP
    Ifrah, N
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (08) : 790 - 795
  • [3] Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia
    C DeLord
    J Treleaven
    J Shepherd
    R Saso
    R L Powles
    [J]. Bone Marrow Transplantation, 1999, 23 : 523 - 525
  • [4] Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia
    DeLord, C
    Treleaven, J
    Shepherd, J
    Saso, R
    Powles, RL
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (05) : 523 - 525
  • [5] Imatinib for chronic myeloid leukaemia relapsing after allogeneic bone marrow transplantation
    Lucesole, M
    Garuti, A
    Sessarego, M
    Di Grazia, C
    van Lint, MT
    Dominietto, A
    Raiola, AM
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Bregante, S
    Galbusera, V
    Bacigalupo, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S150 - S150
  • [6] Haematocolpos following allogenic bone marrow transplantation for chronic myeloid leukaemia
    Jain, SP
    Henry, RJW
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (12): : 1309 - 1310
  • [7] Eosinophilic Fasciitis following Allogeneic Bone Marrow Transplantation in a Patient with Acute Myeloid Leukaemia
    Chu, Gong-Yao
    Lin, Hsing-Lin
    Chen, Gwo-Shing
    Wu, Ching-Ying
    [J]. ACTA DERMATO-VENEREOLOGICA, 2014, 94 (02) : 221 - 222
  • [8] Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation
    Yong, ASM
    Goldman, JM
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (08) : 827 - 828
  • [9] Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation
    ASM Yong
    JM Goldman
    [J]. Bone Marrow Transplantation, 1999, 23 : 827 - 828
  • [10] Allogeneic bone marrow transplantation for chronic myeloid leukemia
    Gratwohl, A
    Hermans, J
    [J]. BONE MARROW TRANSPLANTATION, 1996, 17 : S7 - S9